Suppr超能文献

乙酰唑胺和氢氯噻嗪序贯呋塞米与呋塞米和氢氯噻嗪序贯呋塞米治疗肾病性水肿成人患者的随机试验。

Acetazolamide and Hydrochlorothiazide Followed by Furosemide Versus Furosemide and Hydrochlorothiazide Followed by Furosemide for the Treatment of Adults With Nephrotic Edema: A Randomized Trial.

机构信息

AJA University of Medical Sciences, Tehran, Iran; Shiraz Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

AJA University of Medical Sciences, Tehran, Iran.

出版信息

Am J Kidney Dis. 2017 Mar;69(3):420-427. doi: 10.1053/j.ajkd.2016.10.022. Epub 2016 Dec 30.

Abstract

BACKGROUND

Nephrotic edema is considered refractory if it does not respond to maximum or near-maximum doses of loop diuretics. This condition can be treated with loop diuretics and thiazides. However, animal studies show that the simultaneous downregulation of pendrin with acetazolamide and inhibition of the sodium-chloride cotransporter with hydrochlorothiazide generates significant diuresis, and furosemide administration following a pendrin inhibitor potentiates furosemide's diuretic effect. Therefore, we performed this study to compare the efficacy of acetazolamide and hydrochlorothiazide followed by furosemide versus furosemide and hydrochlorothiazide followed by furosemide for treatment of refractory nephrotic edema.

STUDY DESIGN

Randomized, double-blind, 2-arm, parallel trial.

SETTING & PARTICIPANTS: 20 patients with refractory nephrotic edema despite treatment with 80mg of furosemide daily and creatinine clearance > 60mL/min.

INTERVENTION

Patients were randomly assigned to 2 groups: group 1 (n=10) received 250mg of acetazolamide and 50mg of hydrochlorothiazide daily and group 2 (n=10) received 40mg of furosemide and 50mg of hydrochlorothiazide daily for 1 week in phase 1. In phase 2, both groups received 40mg of furosemide daily for 2 weeks.

OUTCOMES

The primary outcome was absolute change in weight before and at the end of each phase.

MEASUREMENTS

Weight and 24-hour urine volume at baseline and the end of each phase.

RESULTS

The mean weight decrease was of significantly larger magnitude in group 1 compared with group 2 at the end of phase 1 (-1.4±0.52 [SD] vs -0.65±0.41kg; P=0.001) and phase 2 (-1.6±0.84 vs -0.5±0.47kg; P=0.005). The increase in 24-hour urine volume was also significantly higher in group 1 at the end of phase 2.

LIMITATIONS

Small sample size, short follow-up duration, and lack of serum bicarbonate and chloride measurement.

CONCLUSIONS

Acetazolamide and hydrochlorothiazide followed by furosemide is more effective than furosemide and hydrochlorothiazide followed by furosemide for the treatment of refractory nephrotic edema.

摘要

背景

如果肾病性水肿对最大或接近最大剂量的袢利尿剂没有反应,则认为其为难治性水肿。这种情况可以使用袢利尿剂和噻嗪类药物进行治疗。然而,动物研究表明,同时下调 pendrin 与乙酰唑胺,并抑制氯化钠共转运蛋白与氢氯噻嗪,可产生显著的利尿作用,并且在使用 pendrin 抑制剂后给予呋塞米可增强呋塞米的利尿作用。因此,我们进行了这项研究,以比较乙酰唑胺和氢氯噻嗪后继以呋塞米与呋塞米和氢氯噻嗪后继以呋塞米治疗难治性肾病性水肿的疗效。

研究设计

随机、双盲、2 臂、平行试验。

设置和参与者

20 例难治性肾病性水肿患者,尽管每天接受 80mg 呋塞米治疗且肌酐清除率>60mL/min,但仍未得到缓解。

干预

患者被随机分配到 2 组:第 1 组(n=10)每天接受 250mg 乙酰唑胺和 50mg 氢氯噻嗪,第 2 组(n=10)每天接受 40mg 呋塞米和 50mg 氢氯噻嗪,为期 1 周。在第 2 阶段,两组患者均每天接受 40mg 呋塞米,为期 2 周。

结局

主要结局为每个阶段前后体重的绝对变化。

测量

基线和每个阶段结束时的体重和 24 小时尿量。

结果

与第 2 组相比,第 1 组在第 1 阶段(-1.4±0.52[SD] vs -0.65±0.41kg;P=0.001)和第 2 阶段(-1.6±0.84 vs -0.5±0.47kg;P=0.005)结束时体重下降幅度明显更大。第 2 阶段结束时,第 1 组 24 小时尿量增加也明显更高。

局限性

样本量小,随访时间短,以及缺乏血清碳酸氢盐和氯的测量。

结论

乙酰唑胺和氢氯噻嗪后继以呋塞米治疗难治性肾病性水肿比呋塞米和氢氯噻嗪后继以呋塞米更有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验